IL6 and ovarian carcinoma: In summary, the drug resistance of the ovarian cancer cells was associated with large-scale changes in the regulation of KLF4 target genes and with gene expression changes in a subset of genes, including IL6, for which the differences between sensitive and resistant cells were further potentiated in response to 7 μM cisplatin treatment.